Side-chain-constrained amino acids
are useful tools to modulate
the biological properties of peptides. In this study, we applied side-chain
constraints to apelin-13 (Ape13) by substituting the Pro12 and Phe13
positions, affecting the binding affinity and signaling profile on
the apelin receptor (APJ). The residues 1Nal, Trp, and Aia were found
to be beneficial substitutions for Pro12, and the resulting analogues
displayed high affinity for APJ (K
i
0.08–0.18 nM vs Ape13 K
i
0.7 nM). Besides, constrained (d-Tic) or
α,α-disubstituted residues (Dbzg; d-α-Me-Tyr(OBn)) were favorable for the Phe13 position. Compounds 47 (Pro12-Phe13 replaced by Aia-Phe, K
i
0.08 nM) and 53 (Pro12-Phe13
replaced by 1Nal–Dbzg, K
i
0.08 nM) are the most potent Ape13 analogues activating
the Gα12 pathways (53, EC50 Gα12 2.8 nM vs Ape13, EC50 43 nM) known
to date, displaying high affinity, resistance to ACE2 cleavage as
well as improved pharmacokinetics in vitro (t
1/2 5.8–7.3 h in rat plasma) and in vivo.